Lombard Odier Asset Management (Switzerland)’s United Therapeutics UTHR Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$355K	Hold	655	–	–	0.01%	407
2026 Q1	$388K	Buy	+655	New	+$326K	0.01%	386
2023 Q2	–	Sell	-25,873	Closed	-$5.79M	–	376
2023 Q1	$5.79M	Sell	25,873 -25,460	-50%	-$6.28M	0.51%	55
2022 Q4	$14.3M	Buy	51,333 +3,539	+7%	+$893K	1.14%	32
2022 Q3	$10M	Sell	47,794 -18,297	-28%	-$4.09M	0.85%	39
2022 Q2	$15.6M	Buy	66,091 +19,012	+40%	+$3.87M	1.32%	32
2022 Q1	$8.45M	Buy	+47,079	New	+$8.97M	0.66%	50

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Lombard Odier Asset Management (Switzerland)'s UTHR Position: Q2 2026 in Review

Lombard Odier Asset Management (Switzerland) held its United Therapeutics (UTHR) position steady in Q2 2026 at 655 shares worth $355K. The position accounts for 0.01% of the portfolio, ranked #407.

Lombard Odier Asset Management (Switzerland) first reported a position in UTHR in Q1 2022 and has held it in 7 quarters since. The position peaked at $15.6M in Q2 2022. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Lombard Odier Asset Management (Switzerland) held 655 shares of United Therapeutics worth $355K as of Q2 2026.
Lombard Odier Asset Management (Switzerland) left its United Therapeutics share count unchanged in Q2 2026.
United Therapeutics made up 0.01% of Lombard Odier Asset Management (Switzerland)'s portfolio in Q2 2026, its #407 holding.
Lombard Odier Asset Management (Switzerland) first reported a position in United Therapeutics in Q1 2022 and has held it in 7 quarters since.
Lombard Odier Asset Management (Switzerland)'s United Therapeutics position peaked at $15.6M in Q2 2022.
878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2026, filed 14 Aug 2026.